Next Article in Journal
A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization
Previous Article in Journal
Three-Dimensional Culture of Primary Hepatocytes in a Single-Cell Layer on Poly(vinyl alcohol) Nanofibrous Membrane
Previous Article in Special Issue
Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Tongta et al. Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review. Int. J. Mol. Sci. 2025, 26, 10974

by
Sujitra Tongta
1,†,
Titiwat Sungkaworn
2,† and
Nutthapoom Pathomthongtaweechai
2,*
1
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
2
Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan 10540, Thailand
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2026, 27(5), 2365; https://doi.org/10.3390/ijms27052365
Submission received: 6 February 2026 / Accepted: 10 February 2026 / Published: 3 March 2026
(This article belongs to the Special Issue Recent Research in Gut Microbiota–Gut–Brain Axis)
In the original publication [1], there are 1 reference is retracted, which need to be corrected.
Correction for updated references
Reference 59 in the original manuscript has been retracted by the publisher and has been removed from the article.
Text Correction (Section 2, Paragraph 2):
Original text: “These hypothalamic circuits serve as the central hub for the gut–brain axis, integrating both short- and long-term signals [57–59].”
Corrected text: “These hypothalamic circuits serve as the central hub for the gut–brain axis, integrating both short- and long-term signals [57,58].”
Reference List Correction:
Original Reference 59: Ashique, S.; Mohanto, S.; Ahmed, M.G.; Mishra, N.; Garg, A.; Chellappan, D.K.; Omara, T.; Iqbal, S.; Kahwa, I. Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application. Heliyon 2024, 10, e34092. https://doi.org/10.1016/j.heliyon.2024.e34092.
Correction: Reference 59 has been removed from the reference list. All subsequent references have been renumbered (original references 60–219 are now references 59–218).
Impact of Correction:
The removal of this retracted reference does not affect the scientific conclusions of the article. The statements previously supported by this reference remain valid based on other cited literature and the primary findings of our meta-analysis. The authors apologize for inadvertently citing retracted literature and regret any confusion this may have caused. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Tongta, S.; Sungkaworn, T.; Pathomthongtaweechai, N. Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review. Int. J. Mol. Sci. 2025, 26, 10974. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tongta, S.; Sungkaworn, T.; Pathomthongtaweechai, N. Correction: Tongta et al. Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review. Int. J. Mol. Sci. 2025, 26, 10974. Int. J. Mol. Sci. 2026, 27, 2365. https://doi.org/10.3390/ijms27052365

AMA Style

Tongta S, Sungkaworn T, Pathomthongtaweechai N. Correction: Tongta et al. Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review. Int. J. Mol. Sci. 2025, 26, 10974. International Journal of Molecular Sciences. 2026; 27(5):2365. https://doi.org/10.3390/ijms27052365

Chicago/Turabian Style

Tongta, Sujitra, Titiwat Sungkaworn, and Nutthapoom Pathomthongtaweechai. 2026. "Correction: Tongta et al. Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review. Int. J. Mol. Sci. 2025, 26, 10974" International Journal of Molecular Sciences 27, no. 5: 2365. https://doi.org/10.3390/ijms27052365

APA Style

Tongta, S., Sungkaworn, T., & Pathomthongtaweechai, N. (2026). Correction: Tongta et al. Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review. Int. J. Mol. Sci. 2025, 26, 10974. International Journal of Molecular Sciences, 27(5), 2365. https://doi.org/10.3390/ijms27052365

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop